MedPath
NMPA Approval

Camrelizumab for Injection

国药准字S20190027

May 29, 2019

Drug Information

注射用卡瑞利珠单抗

艾瑞卡

艾瑞卡

注射剂

200mg/瓶

生物制品

May 29, 2019

Company Information

Applicant Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区凤里街350号

Manufacturing Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区凤里街350号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用卡瑞利珠单抗 - NMPA 批准文号 | MedPath